Exor, the investment company controlled by Italy’s Agnelli family, has agreed alongside Lifenet Healthcare’s founder to sell a majority stake in the Italian private healthcare group to insurer Reale Mutua. The transaction highlights growing consolidation in Europe’s health services sector as insurers seek closer integration with care providers.
Under the terms of the agreement, Reale Mutua will acquire 80 percent of Lifenet Healthcare, while founder Nicola Bedin will retain a 20 percent stake through his family holding company. The deal values Lifenet at around 600 million euros, according to a person familiar with the matter.
Lifenet operates private hospitals as well as eye and dental clinics across multiple Italian regions. The company expects revenues to exceed 450 million euros this year, reflecting steady demand for private healthcare services in Italy. The group has expanded in recent years through acquisitions and investments in outpatient and diagnostic facilities, positioning itself as a significant player in the country’s non public healthcare segment.
The sale comes at a time when insurers across Europe are increasingly partnering with or acquiring healthcare providers. By integrating insurance coverage with direct access to clinics and diagnostic centers, companies aim to manage costs more effectively and improve patient retention. The model allows insurers to better control treatment pathways while offering policyholders streamlined services.
For Exor, the transaction represents another step in active portfolio management. The holding company has diversified interests spanning automotive, luxury goods, media and healthcare. Monetizing its stake in Lifenet provides capital that can be redeployed into other strategic investments while maintaining exposure to the healthcare sector through ongoing relationships.
Reale Mutua, one of Italy’s longstanding mutual insurers, strengthens its footprint in the healthcare market with this acquisition. Access to Lifenet’s network of facilities could enhance its ability to offer integrated insurance and care packages, a segment that has seen rising demand amid pressures on public health systems.
The Italian healthcare market has been undergoing structural change as demographic trends and budget constraints drive greater reliance on private providers. Outpatient clinics and day surgery centers have attracted particular investor interest due to their relatively lower capital intensity and faster growth prospects compared with large hospital complexes.
Advisers involved in the deal noted strong interest from both industrial buyers and financial investors, underscoring the competitive landscape for quality healthcare assets. Private equity funds have been active in the sector, viewing healthcare services as defensive investments with stable cash flows.
As insurers and healthcare operators deepen ties, further consolidation across European markets appears likely. The Lifenet transaction reflects a broader strategic shift toward integrated healthcare models that combine insurance coverage with direct service provision.
